TRIAL IN PROGRESS: ODRONEXTAMAB, A CD20×CD3 BISPECIFIC ANTIBODY, FOR THE TREATMENT OF RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (R/R MZL)—A COHORT FROM THE ELM‐2 STUDY
Cho, S., Kim, T. M., Taszner, M., Chen, T. Y., Chaudhry, A., Ufkin, M., Uppala, A., Sabir, A., Mohamed, H., Ambati, S., Bachy, E.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2
Poon, M., Walewski, J., Kim, T. M., Cho, S., Jarque, I., Iskierka‐Jażdżewska, E., Prince, H. M., Oh, S. Y., Lim, F., Carpio, C., Tan, T., Ayyappan, S., Gutierrez, A., Li, J., Ufkin, M., Zhu, M., Chaudhry, A., Mohamed, H., Ambati, S., Kim, W. S.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
CLINICAL ACTIVITY OF REGN1979, AN ANTI‐CD20 X ANTI‐CD3 BISPECIFIC ANTIBODY (AB) IN PATIENTS (PTS) WITH (W/) RELAPSED/REFRACTORY (R/R) B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL)
Topp, M.S., Arnason, J., Advani, R., Brown, J.R., Allan, J., Ansell, S., O'Brien, S., Chavez, J., Duell, J., Rosenwald, A., Charnas, R., Ambati, S.R., Adriaens, L., Ufkin, M., Zhu, M., Li, J., Gasparini, P., Jankovic, V., Fiaschi, N., Zhang, W., Hamon, S., Thurston, G., Murphy, A.J., Yancopoulos, G.D., Lowy, I., Sternberg, D., Bannerji, R.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023
Cho, S, Kim, T M, Taszner, M, Chen, T Y, Chaudhry, A, Ufkin, M, Uppala, A, Sabir, A, Mohamed, H, Ambati, S, Bachy, E
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
S868 EMERGING CLINICAL ACTIVITY OF REGN1979, AN ANTI‐CD20 X ANTI‐CD3 BISPECIFIC ANTIBODY (AB), IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL)
Bannerji, R., Arnason, J., Advani, R., Brown, J.R., Allan, J., Ansell, S., O’Brien, S., Chavez, J., Duell, J., Rosenwald, A., Charnas, R., Ambati, S.R., Adriaens, L., Ufkin, M., Zhu, M., Li, J., Gasparini, P., Jankovic, V., Fiaschi, N., Zhang, W., Hamon, S., Thurston, G., Murphy, A.J., Yancopoulos, G.D., Lowy, I., Sternberg, D., Topp, M.S.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article